The incidences of prostate and pancreatic cancer for BRCA1 and BRCA2 mutation carriers were obtained by multiplying the cohort and calendar period age-specific incidence rates from the general population. This evidence concerns the gene BRCA1 and familial pancreatic carcinoma.